1. Home
  2. ETV vs AMPH Comparison

ETV vs AMPH Comparison

Compare ETV & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETV
  • AMPH
  • Stock Information
  • Founded
  • ETV 2005
  • AMPH 1996
  • Country
  • ETV United States
  • AMPH United States
  • Employees
  • ETV N/A
  • AMPH N/A
  • Industry
  • ETV Investment Managers
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETV Finance
  • AMPH Health Care
  • Exchange
  • ETV Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • ETV 1.4B
  • AMPH 1.1B
  • IPO Year
  • ETV N/A
  • AMPH 2014
  • Fundamental
  • Price
  • ETV $13.24
  • AMPH $23.73
  • Analyst Decision
  • ETV
  • AMPH Buy
  • Analyst Count
  • ETV 0
  • AMPH 4
  • Target Price
  • ETV N/A
  • AMPH $40.67
  • AVG Volume (30 Days)
  • ETV 252.5K
  • AMPH 578.6K
  • Earning Date
  • ETV 01-01-0001
  • AMPH 05-07-2025
  • Dividend Yield
  • ETV 8.75%
  • AMPH N/A
  • EPS Growth
  • ETV N/A
  • AMPH N/A
  • EPS
  • ETV N/A
  • AMPH 2.77
  • Revenue
  • ETV N/A
  • AMPH $730,659,000.00
  • Revenue This Year
  • ETV N/A
  • AMPH $2.32
  • Revenue Next Year
  • ETV N/A
  • AMPH $6.60
  • P/E Ratio
  • ETV N/A
  • AMPH $8.99
  • Revenue Growth
  • ETV N/A
  • AMPH 8.05
  • 52 Week Low
  • ETV $11.05
  • AMPH $22.64
  • 52 Week High
  • ETV $13.50
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • ETV 56.91
  • AMPH 47.79
  • Support Level
  • ETV $12.98
  • AMPH $23.68
  • Resistance Level
  • ETV $13.28
  • AMPH $25.36
  • Average True Range (ATR)
  • ETV 0.19
  • AMPH 0.80
  • MACD
  • ETV 0.09
  • AMPH 0.26
  • Stochastic Oscillator
  • ETV 92.96
  • AMPH 70.00

About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest

Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: